Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
March 10, 2009
SYNOSIA ANNOUNCES SECOND AGREEMENT WITH ROCHE
March 9, 2009
IGENICA APPOINTS DR. MIKE ROTHE AS CEO AFTER CLOSING SERIES A FINANCING
March 3, 2009
ACHAOGEN SIGNS $26.6 MILLION CONTRACT WITH NIAID FOR DEVELOPMENT OF NEW THERAPY TO TREAT RESISTANT STRAINS OF NIAID CATEGORY A AND B PRIORITY PATHOGENS
February 24, 2009
PEARL THERAPEUTICS SECURES $8 MILLION IN DEBT FINANCING
February 9, 2009
ENTREMED PRESENTS INITIAL CLINICAL RESULTS FOR ENMD-2076
February 9, 2009
BIOTECHS BEFRIEND NON-DILUTIVE FUNDS
February 3, 2009
ACHAOGEN INITIATES PHASE 1 TRIAL OF ACHN-490 FOR TREATMENT OF MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS
January 8, 2009
ACHAOGEN RECEIVES ₤4.1 MILLION AWARD FROM THE WELLCOME TRUST TO ADVANCE ITS NEOGLYCOSIDES PORTFOLIO
January 7, 2009
ANAPHORE, INC. ANNOUNCES $25 MILLION SERIES A FINANCING
« Previous Page
1
…
101
102
103